MindFrame  awarded third patent for Capture LP thrombectomy technology

19 January 2012

Irvine, Calif. USA. MindFrame Inc. has announced the issuance of a third patent for its breakthrough thrombectomy technology.

The company's technology is used to treat ischemic stroke therapy, in which rapid flow restoration and clot retrieval is essential to prevent irreversible deterioration of brain function in millions of patients suffering from acute ischemic stroke.

“We are proud that our achievements in revolutionary proprietary technology are being recognized,” says Ken Charhut, president and CEO of MindFrame Inc. “Our global mission is to continue leading technology development with more ischemic stroke solutions for our clinicians that allow successful procedural and clinical outcomes for their patients.”

The MindFrame Therapy Solutions technology portfolio was recently expanded to include the MindFrame Capture LP 4-mm diameter and multiple shorter-length–sized low profile devices. The MindFrame Capture LP is the first and only device that can be deployed through smaller microcatheters to improve navigation through tortuous vessels.

MindFrame LP devices provide clinicians with unprecedented access to thrombus aspiration locally and proximally as a result of the reduced microcatheter size. In addition, the devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.

MindFrame Capture LP is not approved for sale in the United States.

Further information

The company's patents are: US Patent Nos. 8,088,140; 8,066,757; 8,070,791.

To top